Literature DB >> 3031189

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

M R Shalaby, M A Palladino, S E Hirabayashi, T E Eessalu, G D Lewis, H M Shepard, B B Aggarwal.   

Abstract

The interaction of highly purified recombinant human tumor necrosis factor-alpha (rTNF-alpha) with human polymorphonuclear neutrophils (PMNs) was investigated. Binding of 125I-rTNF-alpha to PMN reached maximum levels in 30 min at 37 degrees C and in 2 h at 4 degrees C. Scatchard analysis of competitive binding data indicated approximately 6000 receptor sites per cell and a Kd of 1.37 nM. Binding data at 37 degrees C indicated a rapid internalization of rTNF-alpha. Following this receptor-mediated interaction, recombinant TNF-alpha was found to inhibit the migration of PMNs under agarose and to enhance PMN production of superoxide anion (O-2) in a dose-dependent manner. Furthermore, rTNF-alpha-activated PMNs caused a marked disruption of human umbilical-vein-derived endothelial cell monolayers and caused inhibition of their proliferative activities. These data substantiate the role of TNF-alpha as an activator of PMN functions and indicate that PMN/TNF-alpha/endothelial cell interactions may play a major role in inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031189     DOI: 10.1002/jlb.41.3.196

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  55 in total

1.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Mechanism of GM-CSF stimulation of neutrophils.

Authors:  R G Coffey
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.

Authors:  K Vandevyvere; F P Luyten; P Verschueren; R Lories; S Segaert; R Westhovens
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

4.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Tumour necrosis factor, IL-1 and IL-6 in bronchoalveolar washings and their in vitro production during Nippostrongylus brasiliensis infection.

Authors:  N Benbernou; P Matsiota-Bernard; C Jolivet; P Ougen; M Guenounou
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytes.

Authors:  E S Luedke; J L Humes
Journal:  Agents Actions       Date:  1989-06

8.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice.

Authors:  D Nowak; T Pietras; A Antczak; M Król; G Piasecka
Journal:  Antonie Van Leeuwenhoek       Date:  1993-01       Impact factor: 2.271

Review 10.  The role of free oxygen radicals in the expulsion of primary infections of Nippostrongylus brasiliensis.

Authors:  N C Smith
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.